Oxford Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-146,637
| Closed | -$1.77M | – | 443 |
|
|
2019
Q4 | $1.77M | Sell |
146,637
-6,444
| -4% | -$78K | 0.05% | 494 |
|
|
2019
Q3 | $2.16M | Buy |
+153,081
| New | +$2.16M | 0.05% | 490 |
|
|
2019
Q2 | – | Sell |
-141,792
| Closed | -$1.67M | – | 1739 |
|
|
2019
Q1 | $1.67M | Buy |
141,792
+82,321
| +138% | +$967K | 0.04% | 668 |
|
|
2018
Q4 | $795K | Buy |
+59,471
| New | +$795K | 0.02% | 971 |
|
|
2017
Q4 | – | Sell |
-289,058
| Closed | -$5.52M | – | 1644 |
|
|
2017
Q3 | $5.52M | Sell |
289,058
-116,636
| -29% | -$2.23M | 0.11% | 202 |
|
|
2017
Q2 | $4.79M | Buy |
405,694
+168,377
| +71% | +$1.99M | 0.1% | 221 |
|
|
2017
Q1 | $2.6M | Sell |
237,317
-130,317
| -35% | -$1.43M | 0.06% | 341 |
|
|
2016
Q4 | $2.67M | Buy |
367,634
+121,167
| +49% | +$880K | 0.09% | 231 |
|
|
2016
Q3 | $1.6M | Buy |
246,467
+149,176
| +153% | +$970K | 0.05% | 442 |
|
|
2016
Q2 | $531K | Sell |
97,291
-7,604
| -7% | -$41.5K | 0.02% | 581 |
|
|
2016
Q1 | $491K | Buy |
104,895
+22,810
| +28% | +$107K | 0.01% | 614 |
|
|
2015
Q4 | $422K | Buy |
82,085
+10,679
| +15% | +$54.9K | 0.01% | 701 |
|
|
2015
Q3 | $268K | Sell |
71,406
-12,459
| -15% | -$46.8K | 0.01% | 554 |
|
|
2015
Q2 | $504K | Buy |
+83,865
| New | +$504K | 0.01% | 527 |
|
|
2013
Q3 | – | Sell |
-41,554
| Closed | -$72K | – | 810 |
|
|
2013
Q2 | $72K | Buy |
+41,554
| New | +$72K | ﹤0.01% | 836 |
|